Journal article
The TGF-β response toLeishmania chagasi in the absence of IL-12
European journal of immunology, Vol.32(12), pp.3556-3565
12/2002
DOI: 10.1002/1521-4141(200212)32:12<3556::AID-IMMU3556>3.0.CO;2-Q
PMID: 12516540
Abstract
Cure of leishmaniasis requires a type 1 immune response characterized by IFN-gamma production. Leishmania major infection leads to a type 2 response suppressing cure of susceptible BALB/c mice, and L. major causes an exacerbated type 2 response in mouse strains with a gene knockout (KO) such that they lack IL-12p40 (IL-12KO mice). In contrast, type 1 responses are inhibited by TGF-beta without Th2 cell expansion in BALB/c mice infected with L. chagasi. We questioned whether the type 2 or the TGF-beta response would dominate during L. chagasi infection of IL-12KO mice. C57BL/6 mice developed self-resolving L. chagasi infection with abundant IFN-gamma. In contrast, L. chagasi disease was exacerbated and IFN-gamma was low in IL-12KO mice. Total TGF-beta was significantly higher in IL-12KO than control C57BL/6 mice, but IL-4 and IL-10 levels were similar. TGF-beta was further augmented in IL-12/IFN-gamma double-KO mice. Thus, in contrast to L. major, the TGF-beta response was exacerbated whereas type 2 cells were not expanded during L. chagasi infection of IL-12KO mice. We conclude that L. chagasi has an inherent propensity to elicit a prominent TGF-beta response that either suppresses, or is suppressed by, a type 1 response. We propose this be termed a "type 3" immune response, which can antagonize a type 1 response.
Details
- Title: Subtitle
- The TGF-β response toLeishmania chagasi in the absence of IL-12
- Creators
- Mary E Wilson - Veterans' Affairs Medical Center, Department of Internal Medicine, University of Iowa, Iowa City 52242, USA. mary-wilson@uiowa.eduThomas J ReckerNilda E RodriguezBetty M YoungKindra K BurnellJudy A StreitJoel N Kline
- Resource Type
- Journal article
- Publication Details
- European journal of immunology, Vol.32(12), pp.3556-3565
- DOI
- 10.1002/1521-4141(200212)32:12<3556::AID-IMMU3556>3.0.CO;2-Q
- PMID
- 12516540
- NLM abbreviation
- Eur J Immunol
- ISSN
- 0014-2980
- eISSN
- 1521-4141
- Publisher
- Germany
- Grant note
- R01 AI45540 / NIAID NIH HHS HL59324 / NHLBI NIH HHS R03 TW01369 / FIC NIH HHS R01 AI48822 / NIAID NIH HHS
- Language
- English
- Date published
- 12/2002
- Academic Unit
- Microbiology and Immunology; Occupational and Environmental Health; International Programs; Epidemiology; Internal Medicine
- Record Identifier
- 9984001135002771
Metrics
21 Record Views